Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT07089823

A Study of YP05002 in Healthy Participants

Led by Yaopharma Co., Ltd. · Updated on 2025-08-06

76

Participants Needed

1

Research Sites

45 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants

CONDITIONS

Official Title

A Study of YP05002 in Healthy Participants

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Willing and able to comply with all scheduled visits, treatment plan, laboratory tests, and other study procedures.
  • Healthy male and female participants aged 18-65 years (both inclusive).
  • In good health as determined by the Investigator, with no clinically significant findings from medical/psychiatric history, physical examination, 12-lead ECG, vital signs measurements, clinical laboratory evaluations.
Not Eligible

You will not qualify if you...

  • Evidence of any clinically significant active or chronic disease.
  • Use of drugs affecting absorption, distribution, metabolism, or excretion within 14 days or within 5 half-lives prior to first dose; gastrointestinal disorders with impaired gastric emptying; or prolonged use of medications that affect gastrointestinal motility.
  • Clinically relevant acute or chronic medical conditions or diseases posing safety risk or interfering with study assessments.
  • Any malignancy (except basal cell carcinoma and squamous cell carcinoma of the skin) in the previous 5 years.
  • Diagnosis of any type of pancreatitis.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Nucleus Network Melbourne Clinic

Melbourne, Victoria, Australia, 3004

Actively Recruiting

Loading map...

Research Team

Y

Yalei Xie

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

8

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here